Twist Bioscience
TWST
146 hedge funds and large institutions have $1.68B invested in Twist Bioscience in 2020 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 62 increasing their positions, 35 reducing their positions, and 10 closing their positions.
564% more call options, than puts
Call options by funds: $5.31M | Put options by funds: $800K
280% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 10
77% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 35
74% more capital invested
Capital invested by funds: $967M → $1.68B (+$713M)
24% more funds holding
Funds holding: 118 → 146 (+28)
5.99% more ownership
Funds ownership: 77.45% → 83.43% (+6%)
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$54.1M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$35.9M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$29.4M |
| 4 |
State Street
Boston,
Massachusetts
|
+$23.1M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$17M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$42.8M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$33.2M |
| 3 |
Millennium Management
New York
|
-$9.77M |
| 4 |
P3I
Progeny 3 Inc
Kirkland,
Washington
|
-$5.76M |
| 5 |
TCM
Tao Capital Management
San Francisco,
California
|
-$4.85M |
TWST Hedge Fund Activity: Q2 2020 in Review
146 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q2 2020, worth a combined $1.68B — up 74% from $967M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new TWST positions and 10 closed out — a net gain of 28 holders — while 62 added to existing stakes and 35 trimmed.
The largest buyer was Invesco, adding an estimated $54.1M. The largest seller was Fidelity Investments, cutting an estimated $42.8M.
- 146 institutional investors held Twist Bioscience (TWST) as of Q2 2020, up from 118 in Q1 2020.
- Funds reported $1.68B of Twist Bioscience stock for Q2 2020, up 74% quarter-over-quarter.
- 38 funds opened new Twist Bioscience positions in Q2 2020 and 10 closed out, a net change of +28 holders.
- The largest Twist Bioscience buyer in Q2 2020 was Invesco, an estimated $54.1M added.
- The largest Twist Bioscience seller in Q2 2020 was Fidelity Investments, an estimated $42.8M sold.
Based on aggregated 13F filings for Q2 2020.